Skip to main content
Top
Published in: American Journal of Clinical Dermatology 6/2017

01-12-2017 | Original Research Article

Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data

Authors: Michael C. Kwa, Jonathan I. Silverberg

Published in: American Journal of Clinical Dermatology | Issue 6/2017

Login to get access

Abstract

Background

Psoriasis, atopic dermatitis or eczema (AD-E), pemphigus, bullous pemphigoid (BP), and hidradenitis are chronic inflammatory skin disorders associated with systemic immune activation, considerable symptom burden, stigma, functional disturbances, and mental health symptoms. All of these might increase cardiovascular risk.

Objective

The objective of this study was to determine whether these inflammatory skin diseases are associated with increased cardiovascular/cerebrovascular risk and/or disease.

Methods

We analyzed data from the 2002–2012 National Inpatient Sample, including a representative 20% sample of all US hospitalizations (n = 72,108,077 adults).

Results

In multivariate logistic regression models with propensity score matching, patients hospitalized with versus without a diagnosis the inflammatory skin diseases examined had higher odds of obesity (odds ratio [95% confidence interval] for pemphigus: 1.16 [1.05–1.29]; BP 1.14 [1.06–1.23]; AD-E: 1.82 [1.79–1.86]; psoriasis: 2.36 [2.32–2.41]; hidradenitis: 2.79 [2.59–3.01]). Inflammatory skin disease was also associated with significantly higher odds of different cardiovascular risk factors, including hypertension (pemphigus: 1.39 [1.31–1.48]; BP 1.96 [1.88–2.05]; AD-E: 1.19 [1.17–1.21]; psoriasis: 1.61 [1.59–1.64]), and diabetes mellitus with complications (pemphigus: 1.34 [1.18–1.52]; BP: 2.06 [1.90–2.24]; AD-E: 1.13 [1.10–1.17]; psoriasis: 1.39 [1.35–1.44]), as well as vascular, cardiovascular, and cerebrovascular disease, including peripheral vascular disease (pemphigus: 1.14 [1.00–1.30]; BP: 1.83 [1.69–1.98]; AD-E: 1.18 [1.14–1.22]; psoriasis: 1.32 [1.28–1.35]), peripheral and visceral atherosclerosis (BP: 1.67 [1.53–1.81]; AD-E: 1.16 [1.12–1.20]; psoriasis: 1.27 [1.24–1.30]), pulmonary circulation disorders (pemphigus: 1.67 [1.39–2.01]; BP: 2.17 [1.92–2.45]; AD-E: 1.39 [1.33–1.45]; psoriasis: 1.37 [1.31–1.43]), congestive heart failure (pemphigus: 1.75 [1.60–1.90]; BP: 2.82 [2.68–2.98]; AD-E: 1.10 [1.07–1.13]; psoriasis: 1.05 [1.02–1.07]), history of transient ischemic attack (pemphigus: 1.36 [1.14–1.62]; BP: 2.03 [1.83–2.26]; AD-E: 1.19 [1.15–1.23]; psoriasis: 1.31 [1.26–1.36]), and cerebrovascular disease. In stratified analyses, multiple inflammatory skin diseases were associated with significantly higher rates of obesity, hypertension, and/or diabetes in patients aged <50 years and females.

Conclusions

Psoriasis, pemphigus, BP, AD-E, and hidradenitis were all associated with increased cardiovascular and cerebrovascular risk, especially at younger age.
Literature
1.
go back to reference Hsu DY, Gordon K, Silverberg JI. The inpatient burden of psoriasis in the United States. J Am Acad Dermatol. 2016;75(1):33–41.CrossRefPubMed Hsu DY, Gordon K, Silverberg JI. The inpatient burden of psoriasis in the United States. J Am Acad Dermatol. 2016;75(1):33–41.CrossRefPubMed
2.
go back to reference Silverberg JI. Health care utilization, patient costs, and access to care in US adults with eczema: a population-based study. JAMA Dermatol. 2015;151(7):743–52.CrossRefPubMed Silverberg JI. Health care utilization, patient costs, and access to care in US adults with eczema: a population-based study. JAMA Dermatol. 2015;151(7):743–52.CrossRefPubMed
3.
go back to reference Hsu D, Brieva J, Silverberg JI. Costs of care for hospitalization for pemphigus in the United States. JAMA Dermatol. 2016;152(6):645–54.CrossRefPubMed Hsu D, Brieva J, Silverberg JI. Costs of care for hospitalization for pemphigus in the United States. JAMA Dermatol. 2016;152(6):645–54.CrossRefPubMed
4.
go back to reference Ren Z, Hsu D, Brieva J, Silverberg N, Langan S, Silverberg J. Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the USA. Br J Dermatol. 2017;176(1):87–99.CrossRefPubMed Ren Z, Hsu D, Brieva J, Silverberg N, Langan S, Silverberg J. Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the USA. Br J Dermatol. 2017;176(1):87–99.CrossRefPubMed
5.
go back to reference Desai N, Shah P. High burden of hospital resource utilisation in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics. Br J Dermatol. 2017;176(4):1048–55.CrossRefPubMed Desai N, Shah P. High burden of hospital resource utilisation in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics. Br J Dermatol. 2017;176(4):1048–55.CrossRefPubMed
6.
go back to reference Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014–24.CrossRefPubMed Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014–24.CrossRefPubMed
7.
go back to reference Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866–73.CrossRefPubMed Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866–73.CrossRefPubMed
8.
go back to reference Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95.CrossRefPubMed Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95.CrossRefPubMed
9.
go back to reference Silverberg JI, Becker L, Kwasny M, Menter A, Cordoro KM, Paller AS. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol. 2015;151(2):144–52.CrossRefPubMed Silverberg JI, Becker L, Kwasny M, Menter A, Cordoro KM, Paller AS. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol. 2015;151(2):144–52.CrossRefPubMed
10.
go back to reference Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol. 2015;135(3):721–8.e6. Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol. 2015;135(3):721–8.e6.
11.
go back to reference Silverberg JI. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy. 2015;70(10):1300–8.CrossRefPubMed Silverberg JI. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy. 2015;70(10):1300–8.CrossRefPubMed
12.
go back to reference Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol. 2015;72(4):606–16.e4. Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol. 2015;72(4):606–16.e4.
13.
go back to reference Ambiel MV, Roselino AM. Prevalence of metabolic syndrome and its components in a Brazilian sample of pemphigus patients. An Bras Dermatol. 2014;89(5):752–6.CrossRefPubMedPubMedCentral Ambiel MV, Roselino AM. Prevalence of metabolic syndrome and its components in a Brazilian sample of pemphigus patients. An Bras Dermatol. 2014;89(5):752–6.CrossRefPubMedPubMedCentral
14.
go back to reference Forsti AK, Jokelainen J, Timonen M, Tasanen K. Risk of death in bullous pemphigoid: a retrospective database study in Finland. Acta Derm Venereol. 2016;96(6):758–61.PubMed Forsti AK, Jokelainen J, Timonen M, Tasanen K. Risk of death in bullous pemphigoid: a retrospective database study in Finland. Acta Derm Venereol. 2016;96(6):758–61.PubMed
15.
go back to reference Kibsgaard L, Bay B, Deleuran M, Vestergaard C. A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. Acta Derm Venereol. 2015;95(3):307–11.CrossRefPubMed Kibsgaard L, Bay B, Deleuran M, Vestergaard C. A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. Acta Derm Venereol. 2015;95(3):307–11.CrossRefPubMed
16.
go back to reference Cai SC, Allen JC, Lim YL, Chua SH, Tan SH, Tang MB. Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre. Br J Dermatol. 2014;170(6):1319–26.CrossRefPubMed Cai SC, Allen JC, Lim YL, Chua SH, Tan SH, Tang MB. Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre. Br J Dermatol. 2014;170(6):1319–26.CrossRefPubMed
17.
go back to reference Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GB. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173(5):1142–55.CrossRefPubMed Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GB. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173(5):1142–55.CrossRefPubMed
18.
go back to reference Kouris A, Platsidaki E, Christodoulou C, Armyra K, Korkoliakou P, Stefanaki C, et al. Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study. An Bras Dermatol. 2016;91(5):601–3.CrossRefPubMedPubMedCentral Kouris A, Platsidaki E, Christodoulou C, Armyra K, Korkoliakou P, Stefanaki C, et al. Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study. An Bras Dermatol. 2016;91(5):601–3.CrossRefPubMedPubMedCentral
19.
go back to reference Blome C, Radtke MA, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol. 2016;17(2):163–9.CrossRefPubMed Blome C, Radtke MA, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol. 2016;17(2):163–9.CrossRefPubMed
20.
go back to reference Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl 1):S19–22.CrossRefPubMed Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl 1):S19–22.CrossRefPubMed
21.
go back to reference Rencz F, Gulacsi L, Tamasi B, Karpati S, Pentek M, Baji P, et al. Health-related quality of life and its determinants in pemphigus: a systematic review and meta-analysis. Br J Dermatol. 2015;173(4):1076–80.CrossRefPubMed Rencz F, Gulacsi L, Tamasi B, Karpati S, Pentek M, Baji P, et al. Health-related quality of life and its determinants in pemphigus: a systematic review and meta-analysis. Br J Dermatol. 2015;173(4):1076–80.CrossRefPubMed
22.
go back to reference de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140–7.CrossRefPubMed de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140–7.CrossRefPubMed
23.
go back to reference Kramer U, Schafer T, Behrendt H, Ring J. The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema. Br J Dermatol. 1998;139(6):1040–6.CrossRefPubMed Kramer U, Schafer T, Behrendt H, Ring J. The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema. Br J Dermatol. 1998;139(6):1040–6.CrossRefPubMed
24.
go back to reference ICD-9-CM coding and reporting official guidelines. American Hospital Association, American Medical Record Association, Health Care Financing Administration, National Center for Health Statistics. J Am Med Rec Assoc. 1990;61(10):suppl 1–17. ICD-9-CM coding and reporting official guidelines. American Hospital Association, American Medical Record Association, Health Care Financing Administration, National Center for Health Statistics. J Am Med Rec Assoc. 1990;61(10):suppl 1–17.
25.
go back to reference Hsu D, Brieva J, Nardone B, Silverberg JI. Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid. Br J Dermatol. 2016;174(3):645–8.CrossRefPubMed Hsu D, Brieva J, Nardone B, Silverberg JI. Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid. Br J Dermatol. 2016;174(3):645–8.CrossRefPubMed
26.
go back to reference Hsu DY, Dalal P, Sable KA, Voruganti N, Nardone B, West D, et al. Validation of international classification of disease ninth revision codes for atopic dermatitis. Allergy. Epub 20 Dec 2016. doi:10.1111/all.13113. Hsu DY, Dalal P, Sable KA, Voruganti N, Nardone B, West D, et al. Validation of international classification of disease ninth revision codes for atopic dermatitis. Allergy. Epub 20 Dec 2016. doi:10.​1111/​all.​13113.
27.
go back to reference Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol. 2008;59(6):981–5.CrossRefPubMedPubMedCentral Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol. 2008;59(6):981–5.CrossRefPubMedPubMedCentral
28.
go back to reference Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, et al. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009. Pharmacoepidemiol Drug Saf. 2013;22(8):842–9.CrossRefPubMedPubMedCentral Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, et al. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009. Pharmacoepidemiol Drug Saf. 2013;22(8):842–9.CrossRefPubMedPubMedCentral
29.
go back to reference Kim G, Shlyankevich J, Kimball A. The validity of the diagnostic code for hidradenitis suppurativa in an electronic database. Br J Dermatol. 2014;171(2):338–42.CrossRefPubMedPubMedCentral Kim G, Shlyankevich J, Kimball A. The validity of the diagnostic code for hidradenitis suppurativa in an electronic database. Br J Dermatol. 2014;171(2):338–42.CrossRefPubMedPubMedCentral
30.
go back to reference Vena GA, Vestita M, Cassano N. Psoriasis and cardiovascular disease. Dermatol Ther. 2010;23(2):144–51.CrossRefPubMed Vena GA, Vestita M, Cassano N. Psoriasis and cardiovascular disease. Dermatol Ther. 2010;23(2):144–51.CrossRefPubMed
31.
go back to reference Kupetsky EA, Mathers AR, Ferris LK. Anti-cytokine therapy in the treatment of psoriasis. Cytokine. 2013;61(3):704–12.CrossRefPubMed Kupetsky EA, Mathers AR, Ferris LK. Anti-cytokine therapy in the treatment of psoriasis. Cytokine. 2013;61(3):704–12.CrossRefPubMed
32.
go back to reference Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol. 2008;128(11):2625–30.CrossRefPubMed Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol. 2008;128(11):2625–30.CrossRefPubMed
33.
go back to reference Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132(2):361–70.CrossRefPubMedPubMedCentral Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132(2):361–70.CrossRefPubMedPubMedCentral
34.
go back to reference Xue J, Su W, Chen Z, Ke Y, Du X, Zhou Q. Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study. Mediators Inflamm. 2014;2014:463928.CrossRefPubMedPubMedCentral Xue J, Su W, Chen Z, Ke Y, Du X, Zhou Q. Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study. Mediators Inflamm. 2014;2014:463928.CrossRefPubMedPubMedCentral
35.
go back to reference Zebrowska A, Wagrowska-Danilewicz M, Danilewicz M, Stasikowska-Kanicka O, Cynkier A, Sysa-Jedrzejowska A, et al. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid. Mediators Inflamm. 2013;2013:967987.CrossRefPubMedPubMedCentral Zebrowska A, Wagrowska-Danilewicz M, Danilewicz M, Stasikowska-Kanicka O, Cynkier A, Sysa-Jedrzejowska A, et al. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid. Mediators Inflamm. 2013;2013:967987.CrossRefPubMedPubMedCentral
36.
go back to reference Martin-Ezquerra G, Masferrer E, Pujol RM. Use of biological treatments in patients with hidradenitis suppurativa. G Ital Dermatol Venereol. Epub 16 Dec 2016. Martin-Ezquerra G, Masferrer E, Pujol RM. Use of biological treatments in patients with hidradenitis suppurativa. G Ital Dermatol Venereol. Epub 16 Dec 2016.
37.
go back to reference Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169(2):266–82.CrossRefPubMed Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169(2):266–82.CrossRefPubMed
38.
go back to reference van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol. 2011;164(6):1292–8.CrossRefPubMed van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol. 2011;164(6):1292–8.CrossRefPubMed
39.
go back to reference Khozeimeh F, Savabi O, Esnaashari M. Evaluation of interleukin-1alpha, interleukin-10, tumor necrosis factor-alpha and transforming growth factor-beta in the serum of patients with pemphigus vulgaris. J Contemp Dent Pract. 2014;15(6):746–9.CrossRefPubMed Khozeimeh F, Savabi O, Esnaashari M. Evaluation of interleukin-1alpha, interleukin-10, tumor necrosis factor-alpha and transforming growth factor-beta in the serum of patients with pemphigus vulgaris. J Contemp Dent Pract. 2014;15(6):746–9.CrossRefPubMed
40.
go back to reference Alecu M, Alecu S, Coman G, Galatescu E, Ursaciuc C. ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients. Roum Arch Microbiol Immunol. 1999;58(2):121–30.PubMed Alecu M, Alecu S, Coman G, Galatescu E, Ursaciuc C. ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients. Roum Arch Microbiol Immunol. 1999;58(2):121–30.PubMed
41.
go back to reference Ameglio F, D’Auria L, Cordiali-Fei P, Mussi A, Valenzano L, D’Agosto G, et al. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels. J Biol Regul Homeost Agents. 1997;11(4):148–53.PubMed Ameglio F, D’Auria L, Cordiali-Fei P, Mussi A, Valenzano L, D’Agosto G, et al. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels. J Biol Regul Homeost Agents. 1997;11(4):148–53.PubMed
42.
go back to reference Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis–part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol. 2011;127(6):1420–32.CrossRefPubMed Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis–part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol. 2011;127(6):1420–32.CrossRefPubMed
43.
go back to reference Sampogna F, Picardi A, Chren M-M, Melchi CF, Pasquini P, Masini C, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004;66(4):620–4.CrossRefPubMed Sampogna F, Picardi A, Chren M-M, Melchi CF, Pasquini P, Masini C, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004;66(4):620–4.CrossRefPubMed
44.
go back to reference Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol. 2014;170(2):304–14.CrossRefPubMed Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol. 2014;170(2):304–14.CrossRefPubMed
45.
go back to reference Kantor R, Kim A, Thyssen JP, Silverberg JI. Association of atopic dermatitis with smoking: a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(6):1119–25 e1. Kantor R, Kim A, Thyssen JP, Silverberg JI. Association of atopic dermatitis with smoking: a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(6):1119–25 e1.
46.
go back to reference Miller IM, McAndrew RJ, Hamzavi I. Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):7–16.CrossRefPubMed Miller IM, McAndrew RJ, Hamzavi I. Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):7–16.CrossRefPubMed
47.
go back to reference Bakhshi M, Manifar S, Azizi N, Asayesh H, Mansouri P, Nasiri S, et al. Risk factors in patients with oral pemphigus vulgaris: a case–control study. Gen Dent. 2016;64(3):e10–3.PubMed Bakhshi M, Manifar S, Azizi N, Asayesh H, Mansouri P, Nasiri S, et al. Risk factors in patients with oral pemphigus vulgaris: a case–control study. Gen Dent. 2016;64(3):e10–3.PubMed
48.
go back to reference Wohl Y, Mashiah J, Kutz A, Hadj-Rabia S, Cohen AD. Pemphigus and depression comorbidity: a case control study. Eur J Dermatol. 2015;25(6):602–5.PubMed Wohl Y, Mashiah J, Kutz A, Hadj-Rabia S, Cohen AD. Pemphigus and depression comorbidity: a case control study. Eur J Dermatol. 2015;25(6):602–5.PubMed
49.
go back to reference Wohl Y, Mashiah J, Kutz A, Hadj-Rabia S, Cohen AD. Pemphigus and depression comorbidity: a case control study. Eur J Dermatol. 2015;25(6):602–5.PubMed Wohl Y, Mashiah J, Kutz A, Hadj-Rabia S, Cohen AD. Pemphigus and depression comorbidity: a case control study. Eur J Dermatol. 2015;25(6):602–5.PubMed
50.
go back to reference Do YK, Lakhani N, Malhotra R, Halstater B, Theng C, Østbye T. Association between psoriasis and leisure-time physical activity: findings from the National Health and Nutrition Examination Survey. J Dermatol. 2015;42(2):148–53.CrossRefPubMed Do YK, Lakhani N, Malhotra R, Halstater B, Theng C, Østbye T. Association between psoriasis and leisure-time physical activity: findings from the National Health and Nutrition Examination Survey. J Dermatol. 2015;42(2):148–53.CrossRefPubMed
51.
go back to reference Torres T, Alexandre JM, Mendonça D, Vasconcelos C, Silva BM, Selores M. Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. Am J Clin Dermatol. 2014;15(2):129–35.CrossRefPubMed Torres T, Alexandre JM, Mendonça D, Vasconcelos C, Silva BM, Selores M. Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. Am J Clin Dermatol. 2014;15(2):129–35.CrossRefPubMed
52.
go back to reference Wilson P, Bohjanen K, Ingraham S, Leon A. Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol. 2012;26(11):1345–53.CrossRefPubMed Wilson P, Bohjanen K, Ingraham S, Leon A. Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol. 2012;26(11):1345–53.CrossRefPubMed
53.
go back to reference Strom MA, Silverberg JI. Associations of physical activity and sedentary behavior with atopic disease in United States children. J Pediatr. 2016;174(247–53):e3. Strom MA, Silverberg JI. Associations of physical activity and sedentary behavior with atopic disease in United States children. J Pediatr. 2016;174(247–53):e3.
54.
go back to reference Silverberg JI, Song J, Pinto D, Sherry HY, Gilbert AL, Dunlop DD, et al. Atopic dermatitis is associated with less physical activity in US adults. J Invest Dermatol. 2016;136(8):1714–6.CrossRefPubMedPubMedCentral Silverberg JI, Song J, Pinto D, Sherry HY, Gilbert AL, Dunlop DD, et al. Atopic dermatitis is associated with less physical activity in US adults. J Invest Dermatol. 2016;136(8):1714–6.CrossRefPubMedPubMedCentral
55.
go back to reference Kim A, Silverberg JI. A systematic review of vigorous physical activity in eczema. Br J Dermatol. 2016;174(3):660–2.CrossRefPubMed Kim A, Silverberg JI. A systematic review of vigorous physical activity in eczema. Br J Dermatol. 2016;174(3):660–2.CrossRefPubMed
56.
go back to reference Hsu DY, Gordon K, Silverberg JI. The inpatient burden of psoriasis in the United States. J Am Acad Dermatol. 2016;75(1):33–41.CrossRefPubMed Hsu DY, Gordon K, Silverberg JI. The inpatient burden of psoriasis in the United States. J Am Acad Dermatol. 2016;75(1):33–41.CrossRefPubMed
Metadata
Title
Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data
Authors
Michael C. Kwa
Jonathan I. Silverberg
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 6/2017
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-017-0293-x

Other articles of this Issue 6/2017

American Journal of Clinical Dermatology 6/2017 Go to the issue

Review Article

Pediatric Psoriasis